Status:
COMPLETED
Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina
Lead Sponsor:
Hospital Italiano de Buenos Aires
Collaborating Sponsors:
Ministerio de Salud de Ciudad Autónoma de Buenos Aires
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The main of the study is to describe the incidence in health personnel who present events supposedly attributed to vaccines and immunizations after having received the two components of the Sputnik V ...
Detailed Description
The World Health Organization (WHO) recommends vaccination against coronavirus disease 19 (COVID-19) as a fundamental primary prevention tool to limit the health and economic effects of the pandemic. ...
Eligibility Criteria
Inclusion
- health workers who agree to receive the sputnik V vaccine
Exclusion
- health workers who have a contraindication to receive the sputnik V vaccine
Key Trial Info
Start Date :
January 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04738435
Start Date
January 5 2021
End Date
March 1 2021
Last Update
August 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Italiano de Buenos Aires
Buenos Aires, Buenos Aires F.D., Argentina, C1199ABB